Navegação por autor "Valete-Rosalino, Claudia Maria"
Itens para a visualização no momento 1-8 of 8
-
An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil
Oliveira-Ribeiro, Carla et al. | Data do documento: 2021 -
COVID-19 clinical manifestations in children and adolescents admitted to intensive care in the city of São Carlos, Brazil: a case series
Sartoreli, Ana Luiza Carvalho et al. | Data do documento: 2023 -
Evaluation of polymerase chain reaction in the routine diagnosis for tegumentary leishmaniasis in a referral centre
Fagundes, Aline et al. | Data do documento: 2010 -
Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges
Frota, Aline Xavier et al. | Data do documento: 2021 -
Geospatial analysis of tegumentary leishmaniasis in Rio de Janeiro state, Brazil from 2000 to 2015: species typing and flow of travelers and migrants with leishmaniasis
Miranda, Luciana de Freitas Campos et al. | Data do documento: 2019 -
Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal?
Leite-Silva, Jéssica et al. | Data do documento: 2023 -
Parasite species variation and impact of spatial displacement of the population on cutaneous leishmaniasis in Rio de Janeiro, Brazil
Salgueiro, Mariza M. et al. | Data do documento: 2022 -
Treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate at a primary care unit in Brazil
Duque, Maria Cristina de Oliveira et al. | Data do documento: 2018O antimoniato de meglumina (AM) intralesional (IL), por via subcutânea, é recomendado para o tratamento da leishmaniose cutânea (LC). A frequente falta de recursos nas unidades básicas de saúde costuma dificultar o ...